TIDMSLN

RNS Number : 1317G

Silence Therapeutics PLC

03 June 2013

Notice of General Meeting and Annual Report

03 June 2013

Silence Therapeutics plc (AIM: SLN) announces that its Annual Report & Accounts for the year ended 31 December 2012 and the 2013 Annual General Meeting (AGM) notice were posted to shareholders today. The Annual Report & Accounts for the year ended 31 December 2012 will shortly be available for download at the Company's website www.silence-therapeutics.com

The 2013 AGM will be held at Silence Therapeutics plc, 3 Shortlands Way, London, W6 8DA on 26 June 2013 at 11.00am.

Silence Therapeutics

Ali Mortazavi, chief executive/Timothy Freeborn, finance director +44 (0)333 988 0140

a.mortazavi@silence-therapeutics.com

t.freeborn@silence-therapeutics.com

N+1 Singer

Shaun Dobson/Jenny Wyllie

+44 20 7496 3000

shaun.dobson@n1singer.com

jenny.wyllie@n1singer.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

NOASSLFSDFDSEEM

Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Silence Therapeutics Charts.
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Silence Therapeutics Charts.